Literature DB >> 9133573

Neuromuscular development in the avian paralytic mutant crooked neck dwarf (cn/cn): further evidence for the role of neuromuscular activity in motoneuron survival.

R W Oppenheim1, D Prevette, L J Houenou, M Pincon-Raymond, V Dimitriadou, A Donevan, M O'Donovan, P Wenner, D D Mckemy, P D Allen.   

Abstract

Neuromuscular transmission and muscle activity during early stages of embryonic development are known to influence the differentiation and survival of motoneurons and to affect interactions with their muscle targets. We have examined neuromuscular development in an avian genetic mutant, crooked neck dwarf (cn/cn), in which a major phenotype is the chronic absence of the spontaneous, neurally mediated movements (motility) that are characteristic of avian and other vertebrate embryos and fetuses. The primary genetic defect in cn/cn embryos responsible for the absence of motility appears to be the lack of excitation-contraction coupling. Although motility in mutant embryos is absent from the onset of activity on embryonic days (E) 3-4, muscle differentiation appears histologically normal up to about E8. After E8, however, previously separate muscles fuse or coalesce secondarily, and myotubes exhibit a progressive series of histological and ultrastructural degenerative changes, including disarrayed myofibrils, dilated sarcoplasmic vesicles, nuclear membrane blebbing, mitochondrial swelling, nuclear inclusions, and absence of junctional end feet. Mutant muscle cells do not develop beyond the myotube stage, and by E18-E20 most muscles have almost completely degenerated. Prior to their breakdown and degeneration, mutant muscles are innervated and synaptic contacts are established. In fact, quantitative analysis indicates that, prior to the onset of muscle degeneration, mutant muscles are hyperinnervated. There is increased branching of motoneuron axons and an increased number of synaptic contacts in the mutant muscle on E8. Naturally occurring cell death of limb-innervating motoneurons is also significantly reduced in cn/cn embryos. Mutant embryos have 30-40% more motoneurons in the brachial and lumbar spinal cord by the end of the normal period of cell death. Electrophysiological recordings (electromyographic and direct records form muscle nerves) failed to detect any differences in the activity of control vs. mutant embryos despite the absence of muscular contractile activity in the mutant embryos. The alpha-ryanodine receptor that is genetically abnormal in homozygote cn/cn embryos is not normally expressed in the spinal cord. Taken together, these data argue against the possibility that the mutant phenotype described here is caused by the perturbation of a central nervous system (CNS)-expressed alpha-ryanodine receptor. The hyperinnervation of skeletal muscle and the reduction of motoneuron death that are observed in cn/cn embryos also occur in genetically paralyzed mouse embryos and in pharmacologically paralyzed avian and rat embryos. Because a primary common feature in all three of these models is the absence of muscle activity, it seems likely that the peripheral excitation of muscle by motoneurons during normal development is a major factor in regulating retrograde muscle-derived (or muscle-associated) signals that control motoneuron differentiation and survival.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133573     DOI: 10.1002/(sici)1096-9861(19970512)381:3<353::aid-cne7>3.0.co;2-1

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

1.  Deafening alters neuron turnover within the telencephalic motor pathway for song control in adult zebra finches.

Authors:  N Wang; R Aviram; J R Kirn
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Motoneuron survival is enhanced in the absence of neuromuscular junction formation in embryos.

Authors:  J Terrado; R W Burgess; T DeChiara; G Yancopoulos; J R Sanes; A C Kato
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

3.  Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic-blocking agents.

Authors:  R W Oppenheim; D Prevette; A D'Costa; S Wang; L J Houenou; J M McIntosh
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  A novel type of programmed neuronal death in the cervical spinal cord of the chick embryo.

Authors:  H Yaginuma; M Tomita; N Takashita; S E McKay; C Cardwell; Q W Yin; R W Oppenheim
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

5.  Peripheral target regulation of the development and survival of spinal sensory and motor neurons in the chick embryo.

Authors:  J Calderó; D Prevette; X Mei; R A Oakley; L Li; C Milligan; L Houenou; M Burek; R W Oppenheim
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

6.  Neuromuscular activity blockade induced by muscimol and d-tubocurarine differentially affects the survival of embryonic chick motoneurons.

Authors:  M F Usiak; L T Landmesser
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

Review 7.  Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Authors:  Tokunbor A Lawal; Emily S Wires; Nancy L Terry; James J Dowling; Joshua J Todd
Journal:  Orphanet J Rare Dis       Date:  2020-05-07       Impact factor: 4.123

8.  Genetic deficiency of GABA differentially regulates respiratory and non-respiratory motor neuron development.

Authors:  Matthew J Fogarty; Karen L Smallcombe; Yuchio Yanagawa; Kunihiko Obata; Mark C Bellingham; Peter G Noakes
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

9.  Inhibition of electrical activity by retroviral infection with Kir2.1 transgenes disrupts electrical differentiation of motoneurons.

Authors:  Yone Jung Yoon; Hisashi Kominami; Thomas Trimarchi; Miguel Martin-Caraballo
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.